Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Ciulla

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Expert Opinion on Biological Therapy|January 25, 2026
Biological therapies at 25 years: from incremental advances to revolutionary transformationsThomas A Ciulla
Acta Ophthalmologica Scandinavica|May 20, 2003
Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapyThomas A Ciulla
Retinal Cases & Brief Reports|November 13, 2014
Sustained response to multiple intravitreal triamcinolone acetonide injections in a patient with predominantly occult choroidal neovascularizationAlejandro Oliver, Thomas A Ciulla
Ophthalmology Clinics of North America|November 19, 2002
Novel approaches for retinal drug deliveryDaryl Kurz, Thomas A Ciulla
Ophthalmology Clinics of North America|August 29, 2006
Corticosteroids as antiangiogenic agentsAlejandro Oliver, Thomas A Ciulla
American Journal of Ophthalmology|April 30, 2003
Leber congenital amaurosis associated with optic disk neovascularization and vitreous hemorrhageDaryl Kurz, Thomas A Ciulla
International Ophthalmology Clinics|December 4, 2004
Diagnostic imaging of retinal diseaseGrant M Comer, Thomas A Ciulla
Current Opinion in Ophthalmology|November 4, 2004
Pharmacotherapy for diabetic retinopathyGrant M Comer, Thomas A Ciulla
Current Opinion in Ophthalmology|April 22, 2009
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degenerationThomas A Ciulla, Philip J Rosenfeld
Genes|June 27, 2024
Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and BeyondLucas W Rowe, Thomas A Ciulla
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Expert Opinion on Biological Therapy|January 25, 2026
Biological therapies at 25 years: from incremental advances to revolutionary transformationsThomas A Ciulla
Acta Ophthalmologica Scandinavica|May 20, 2003
Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapyThomas A Ciulla
Retinal Cases & Brief Reports|November 13, 2014
Sustained response to multiple intravitreal triamcinolone acetonide injections in a patient with predominantly occult choroidal neovascularizationAlejandro Oliver, Thomas A Ciulla
Ophthalmology Clinics of North America|November 19, 2002
Novel approaches for retinal drug deliveryDaryl Kurz, Thomas A Ciulla
Ophthalmology Clinics of North America|August 29, 2006
Corticosteroids as antiangiogenic agentsAlejandro Oliver, Thomas A Ciulla
American Journal of Ophthalmology|April 30, 2003
Leber congenital amaurosis associated with optic disk neovascularization and vitreous hemorrhageDaryl Kurz, Thomas A Ciulla
International Ophthalmology Clinics|December 4, 2004
Diagnostic imaging of retinal diseaseGrant M Comer, Thomas A Ciulla
Current Opinion in Ophthalmology|November 4, 2004
Pharmacotherapy for diabetic retinopathyGrant M Comer, Thomas A Ciulla
Current Opinion in Ophthalmology|April 22, 2009
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degenerationThomas A Ciulla, Philip J Rosenfeld
Genes|June 27, 2024
Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and BeyondLucas W Rowe, Thomas A Ciulla
Pageof 12